Company Filing History:
1 out of 70 
1 out of 1 Years Active: 2013
Title: Maria Teresa Frias Lepoureau: Innovator in Vaccine Development
Introduction
Maria Teresa Frias Lepoureau is a distinguished inventor based in Ciudad de la Habana, Cuba. She has made significant contributions to the field of veterinary medicine through her research and innovative inventions. With one patent to her name, she has developed a groundbreaking approach to combating classical swine fever, a critical disease affecting pigs globally.
Latest Patents
Her notable patent is for "Chimeric vaccine antigens against classical swine fever virus." This invention showcases chimeric vaccine antigens that are designed to combat the virus responsible for classical swine fever (CSFV). The vaccine antigens leverage viral subunits coupled with proteins that stimulate both the cellular and humoral immune systems. The distinctive feature of these chimeric antigens is their production in expression systems that ensure correct tertiary structure folding, which is vital for the functionality of the vaccine. The formulations containing these chimeric antigens not only induce an early and robust immune response in vaccinated pigs but also offer full protection against CSFV. Additionally, these vaccine formulations prevent viral transmission from sows to their offspring, demonstrating substantial advancements in animal health through preventive vaccine applications in swine.
Career Highlights
Maria Teresa has worked at prominent institutions that have bolstered her research and development in the field. She has been affiliated with the Centro de Ingeniería Genética y Biotecnología and the Centro Nacional de Sanidad Agropecuaria. Through her roles at these organizations, she has contributed to innovative solutions in biotechnology and animal health, focusing on the improvement of vaccine formulations and their applications.
Collaborations
Throughout her career, Maria has collaborated with notable colleagues, including Jorge Roberto Toledo Alonso and Oliberto Sánchez Ramos. These partnerships have allowed for a rich exchange of ideas and expertise, further enhancing the impact of her work in vaccine development.
Conclusion
Maria Teresa Frias Lepoureau stands out as a pioneer in the development of chimeric vaccine antigens against classical swine fever virus, reflecting her dedication to animal health and innovation. Her contributions have paved the way for significant advancements in veterinary vaccines, ensuring better health and protection for swine populations. As she continues her work, her inventions and collaborations will likely have lasting impacts on the fields of veterinary medicine and biotechnology.